Nicholas McCaul

Nicholas McCaul

Auto-generated profile, based on publicly available information

Nicholas McCaul

Program in Cellular and Molecular Medicine, Boston Children’s Hospital , Boston, MA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2016 in Traffic
Verified
Journal Article
Closed access
PDF file
Lars EllgaardLars Ellgaard
Lars Ellgaard
NMNicholas McCaul
Nicholas McCaul
ACAnna Chatsisvili
Anna Chatsisvili
IBIneke Braakman
Ineke Braakman

28 July 2017 in eLife
Verified
Journal Article
Open access
ESErik Snapp
Erik Snapp
NMNicholas McCaul
Nicholas McCaul
MQMatthias Quandte
Matthias Quandte
ZCZuzana Cabartova
Zuzana Cabartova
IBIlja Bontjer
Ilja Bontjer
IBIneke Braakman
Ineke Braakman
Like all other secretory proteins, the HIV-1 envelope glycoprotein gp160 is targeted to the endoplasmic reticulum (ER) by its signal peptide during synthesis. Proper gp160 folding in the ER requires core glycosylation, disulfide-bond formation and proline isomerization. Signal-peptide cleavage occurs only late after gp160 chain termination and is dependent on folding of the soluble subunit gp120 to a near-native conformation. We here detail the mechanism by which co-translational signal-peptide cleavage is prevented. Conserved residues from the signal peptide and residues downstream of the canonical cleavage site form an extended alpha-helix in the ER membrane, which covers the cleavage site, thus preventing cleavage. A point mutation in the signal peptide breaks the alpha helix allowing co-translational cleavage. We demonstrate that postponed cleavage of gp160 enhances functional folding of the molecule. The change to early cleavage results in decreased viral fitness compared to wild-type HIV.

1 October 2019 in Molecular Immunology
Verified
Journal Article
Closed access
JLJingjing Ling
Jingjing Ling
RCRoss W. Cheloha
Ross W. Cheloha
NMNicholas McCaul
Nicholas McCaul
ZSZhen-Yu J. Sun
Zhen-Yu J. Sun
GWGerhard Wagner
Gerhard Wagner
HPHidde L. Ploegh
Hidde L. Ploegh

14 June 2021 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
NPNovalia Pishesha
Novalia Pishesha
THThibault Harmand
Thibault Harmand
LSLiyan Y. Smeding
Liyan Y. Smeding
WMWeiyi Ma
Weiyi Ma
LLLeif S. Ludwig
Leif S. Ludwig
HPHidde L. Ploegh
Hidde L. Ploegh

1 September 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NMNicholas McCaul
Nicholas McCaul
CPCorey M. Porter
Corey M. Porter
ABAnouk Becker
Anouk Becker
CTChih-Hang Anthony Tang
Chih-Hang Anthony Tang
CWCharlotte Wijne
Charlotte Wijne
MTMatthias C. Truttmann
Matthias C. Truttmann
Fic domain-containing AMP transferases (fic AMPylases) are conserved enzymes that catalyze the covalent transfer of AMP to proteins. This posttranslational modification regulates the function of several proteins, including the ER-resident chaperone Grp78/BiP. Here we introduce a mouse FICD (mFICD) AMPylase knockout mouse model to study fic AMPylase function in vertebrates. We find that mFICD deficiency is well tolerated in unstressed mice. We also show that mFICD-deficient mouse embryonic fibroblasts are depleted of AMPylated proteins. mFICD deletion alters protein synthesis and secretion in splenocytes, including that of IgM, an antibody secreted early during infections, and the proinflammatory cytokine IL-1β, without affecting the unfolded protein response. Finally, we demonstrate that visual nonspatial short-term learning is stronger in old mFICD-/- mice than in wild-type controls while other measures of cognition, memory, and learning are unaffected. Together, our results suggest a role for mFICD in adaptive immunity and neuronal plasticity in vivo.

1 August 2021 in Cell Reports
Verified
Journal Article
Open access
NMNicholas McCaul
Nicholas McCaul
MQMatthias Quandte
Matthias Quandte
IBIlja Bontjer
Ilja Bontjer
GZGuus van Zadelhoff
Guus van Zadelhoff
ALAafke Land
Aafke Land
IBIneke Braakman
Ineke Braakman
Removal of the membrane-tethering signal peptides that target secretory proteins to the endoplasmic reticulum is a prerequisite for proper folding. While generally thought to be removed co-translationally, we report two additional post-targeting functions for the HIV-1 gp120 signal peptide, which remains attached until gp120 folding triggers its removal. First, the signal peptide improves folding fidelity by enhancing conformational plasticity of gp120 by driving disulfide isomerization through a redox-active cysteine. Simultaneously, the signal peptide delays folding by tethering the N terminus to the membrane, until assembly with the C terminus. Second, its carefully timed cleavage represents intramolecular quality control and ensures release of (only) natively folded gp120. Postponed cleavage and the redox-active cysteine are both highly conserved and important for viral fitness. Considering the ∼15% proteins with signal peptides and the frequency of N-to-C contacts in protein structures, these regulatory roles of signal peptides are bound to be more common in secretory-protein biogenesis.